Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation

Analytical Biochemistry

Volumn 397, Issue 1, 2010, Pages 96-106

  Reed, Kerry ^a,b   Poulin, Matthew L ^c   Yan, Liying ^c   Parissenti, Amadeo M ^a,b,d  

^a LAURENTIAN UNIVERSITY   (Canada)

^b SUDBURY REGIONAL HOSPITAL   (Canada)

^c EpigenDx   (United States)

^d NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

ABCB1; Bisulfite sequencing PCR; DNA methylation; Drug resistance; Hypermethylation; Hypomethylation; Mixed methylation; Pyrosequencing

Indexed keywords

ALKYLATION; CELL CULTURE; CELL PROLIFERATION; CLONE CELLS; CLONING; DNA; GENE ENCODING; GENE EXPRESSION; METHYLATION;

ABCB1; BISULFITE-SEQUENCING; DNA METHYLATION; DRUG RESISTANCE; HYPERMETHYLATION; HYPOMETHYLATION; PYROSEQUENCING;

POLYMERASE CHAIN REACTION;

MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; BISULFITE SEQUENCING POLYMERASE CHAIN REACTION; CELL STRAIN MCF 7; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 71749102589     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.10.021     Document Type: Article

References (30)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
2. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 629-656
3. Ballestar E., and Esteller M. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger. Biochem. Cell Biol. 83 (2005) 374-384
4. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., and Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89 (1992) 1827-1831
5. Clark S.J., Harrison J., Paul C.L., and Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22 (1994) 2990-2997
6. Dupont J.M., Tost J., Jammes H., and Gut I.G. De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal. Biochem. 333 (2004) 119-127
7. Tost J., and Gut I.G. DNA methylation analysis by pyrosequencing. Nat. Protoc. 2 (2007) 2265-2275
8. Shaw R.J., Hall G.L., Lowe D., Liloglou T., Field J.K., Sloan P., and Risk J.M. The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression. Arch. Otolaryngol. Head Neck Surg. 134 (2008) 251-256
9. Colella S., Shen L., Baggerly K.A., Issa J.P., and Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. BioTechniques 35 (2003) 146-150
10. Tost J., Dunker J., and Gut I.G. Analysis and quantification of multiple methylation variable positions in CpG islands by pyrosequencing. BioTechniques 35 (2003) 152-156
11. David G.L., Yegnasubramanian S., Kumar A., Marchi V.L., De Marzo A.M., Lin X., and Nelson W.G. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. Cancer Biol. Ther. 3 (2004) 540-548
12. Reed K., Hembruff S.L., Laberge M.L., Villeneuve D.J., Cote G.B., and Parissenti A.M. Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells. Epigenetics 3 (2008) 270-280
13. Chekhun V.F., Kulik G.I., Yurchenko O.V., Tryndyak V.P., Todor I.N., Luniv L.S., Tregubova N.A., Pryzimirska T.V., Montgomery B., Rusetskaya N.V., and Pogribny I.P. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett. 231 (2006) 87-93
14. Kusaba H., Nakayama M., Harada T., Nomoto M., Kohno K., Kuwano M., and Wada M. Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells. Eur. J. Biochem. 262 (1999) 924-932
15. Nakayama M., Wada M., Harada T., Nagayama J., Kusaba H., Ohshima K., Kozuru M., Komatsu H., Ueda R., and Kuwano M. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 92 (1998) 4296-4307
16. Desiderato L., Davey M.W., and Piper A.A. Demethylation of the human MDR1 5' region accompanies activation of P-glycoprotein expression in a HL60 multidrug resistant subline. Somat. Cell Mol. Genet. 23 (1997) 391-400
17. Kantharidis P., El-Osta A., deSilva M., Wall D.M., Hu X.F., Slater A., Nadalin G., Parkin J.D., and Zalcberg J.R. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin. Cancer Res. 3 (1997) 2025-2032
18. Hembruff S.L., Laberge M.L., Villeneuve D.J., Guo B., Veitch Z., Cecchetto M., and Parissenti A.M. Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance. BMC Cancer 8 (2008) 318
19. Liu T., Zhang X., So C.K., Wang S., Wang P., Yan L., Myers R., Chen Z., Patterson A.P., Yang C.S., and Chen X. Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. Carcinogenesis 28 (2007) 488-496
20. Brakensiek K., Wingen L.U., Langer F., Kreipe H., and Lehmann U. Quantitative high-resolution CpG island mapping with pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia. Clin. Chem. 53 (2007) 17-23
21. Silva A.J., Ward K., and White R. Mosaic methylation in clonal tissue. Dev. Biol. 156 (1993) 391-398
22. Vu T.H., Li T., Nguyen D., Nguyen B.T., Yao X.M., Hu J.F., and Hoffman A.R. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics 64 (2000) 132-143
23. Kawaguchi M., Toyama T., Kaneko R., Hirayama T., Kawamura Y., and Yagi T. Relationship between DNA methylation states and transcription of individual isoforms encoded by the protocadherin-α gene cluster. J. Biol. Chem. 283 (2008) 12064-12075
24. Huang D., Lin X., Chen H., Yang Q., Jie Y., Zhai X., and Yin H. Parentally imprinted allele (PIA) typing in the differentially methylated region upstream of the human H19 gene. Forensic Sci. Int. Genet. 2 (2008) 286-291
25. Boumber Y.A., Kondo Y., Chen X., Shen L., Guo Y., Tellez C., Estecio M.R., Ahmed S., and Issa J.P. An Sp1/Sp3 binding polymorphism confers methylation protection. PLoS Genet. 4 (2008) e1000162
26. Milani L., Lundmark A., Nordlund J., Kiialainen A., Flaegstad T., Jonmundsson G., Kanerva J., Schmiegelow K., Gunderson K.L., Lonnerholm G., and Syvanen A.C. Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res. 19 (2009) 1-11
27. Horsthemke B., Lich C., Buiting K., Achmann R., Aulehla-Scholz C., Baumer A., Burger J., Dworniczak B., Glaser D., Holinski-Feder E., et al. Problems in detecting mosaic DNA methylation in Angelman syndrome. Eur. J. Hum. Genet. 11 (2003) 913-915
28. Warnecke P.M., Stirzaker C., Melki J.R., Millar D.S., Paul C.L., and Clark S.J. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphate-treated DNA. Nucleic Acids Res. 25 (1997) 4422-4426
29. Wojdacz T.K., Hansen L.L., and Dobrovic A. A new approach to primer design for the control of PCR bias in methylation studies. BMC Res. Notes 1 (2008) 54
30. Chhibber A., and Schroeder B.G. Single-molecule polymerase chain reaction reduces bias: application to DNA methylation analysis by bisulfite sequencing. Anal. Biochem. 377 (2008) 46-54